[1]
“Design, Synthesis and Molecular Docking Study of N-Heterocyclic Chalcone Derivatives as an Anticancer Agents”., Int. J. Pharm. Sci. Drug Res., vol. 14, no. 1, pp. 78–84, Jan. 2022, doi: 10.25004/IJPSDR.2022.140111.